// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Activation Towards Health Self-Management in Patients with Systemic Lupus Erythematosus

Carolyn Neville - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Addressing the Pediatric Rheumatology Workforce Shortage: Results from the American College of Rheumatology Annual Pediatric Residents Program

Jay Mehta - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Analysis of Cell-of-Origin in Diffuse Large B-Cell Lymphoma in Systemic Lupus Erythematosus, Including Molecular and Clinical Factors Associated with Survival

Basile Tessier-Cloutier - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

An Economic Evaluation on the Impact of Earlier Systemic Lupus Erythematosus (SLE) Diagnosis Using Complement C4d Activation Products in a Multivariate Assay Panel (MAP)

Tom Goss - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

An Evaluation of Utilization Patterns and Appropriateness of Laboratory Tests Among New Referrals to Rheumatologists: Choosing Unwisely!

Azin Ahrari - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Anakinra Treatment Prevents Myocardial Mechanical Dysfunction and Inhibits Histologic Evidence of Myocardial Inflammation in the Mouse Model of Kawasaki Disease

Youngho Lee - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

Anakinra

Anti-NT5c1A Autoantibodies As Biomarkers in Inclusion Body Myositis

Mark Tarnopolsky - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

N/A

Anti-Nuclear Antibodies (ANA) and Air Pollution: Ultrafine Particles and Ozone

Shouao Wang - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessment of Pain Relief with Baricitinib By Treatment History in Patients with Refractory Rheumatoid Arthritis

Amanda Quebe - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Baricitinib

Assessment of the Psychometric Properties of Patient-Reported Outcomes of Depression in SLE

Sherief Marzouk - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Association between Biologic Dmards and Weight Change in Patients with Inflammatory Arthritis

Imran Hassan - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Association of Systemic Lupus Erythematosus (SLE) Genetic Susceptibility Loci with Lupus Nephritis in Children and Adults with SLE

Jingjing Cao - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Atherogenic Index of Plasma in Women with Systemic Lupus Erythematosus and Rheumatoid Arthritis: A 10-Year Potential Predictor of Cardiovascular Disease

Tamer A Gheita - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Atherosclerotic Vascular Events in SLE – an Evolving Story

Jiandong Su - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Autoantibodies to M-Phase Phosphoprotein I (MPP-1: KIF20B) in Systemic Lupus Erythematosus

Eric Campbell - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

N/A

N/A

Autoantibodies to Mi-2 Alpha and Mi-2 Beta in Patients with Myositis

Michaelin Richards - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Autoantibody Testing in Pediatric Localized Scleroderma (LS)

Aidan Porter - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

B and T Cell Phenotypes of First Degree Relatives of RA Patients in an Indigenous North American Cohort

Christine Zhang - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Baseline Pain Severity As a Predictor of Pain Improvement Following Treatment with Tofacitinib in Psoriatic Arthritis

Kurt de Vlam - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Tasocitinib

Biomechanical Therapy for Osteoarthritis of the Knee: A Randomized Controlled Trial

Sarah Heldner - American College of Rheumatology (ACR) , 2018

Therapeutic Area

Disease

Drug/Treatment

Musculoskeletal

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved